Fri.Jul 19, 2024

article thumbnail

Microsoft global outage forces health systems to cancel appointments, delay procedures

STAT

On Thursday, a widespread outage to Microsoft systems took down computers in health systems around the globe, leading many to cancel non-urgent medical appointments and surgeries as they encouraged patients to make plans for disrupted travel and delays in care. “A major worldwide software outage has affected many of our systems at Mass General Brigham,” the hospital system shared in a statement on Friday.

article thumbnail

Kyverna follows oncology’s CAR-T cell playbook for an ultra-rare autoimmune disorder

PharmaVoice

The pharma company is tackling the “stiff person syndrome” that afflicts Celine Dion in a phase 2 trial for its lead CAR-T candidate.

173
173
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Wastewater surveillance group funded by Google founder, Bloomberg sheds dozens of testing sites

STAT

WastewaterSCAN, one of the United States’ largest private entities that provide real-time data on pathogens in wastewater, has stopped collecting data from 43 facilities due to “resource constraints,” according to emails the company sent to staff overseeing these sites. The group — based at Stanford University, in partnership with Emory University — had been collecting samples from 194 sites in 41 states and the District of Columbia, a swath including 39 millio

333
333
article thumbnail

Gilead’s CMO to depart next year

PharmaVoice

Merdad Parsey joined Gilead as its chief medical officer in 2019 and has helped lead the company’s expansion into oncology, with mixed success.

147
147
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Opinion: To overcome the overdose crisis, addiction treatment must be integrated into the health care system

STAT

The first time I saw Maya (not her real name) huddled under blankets in a hospital bed in 2013, she had been to dozens of inpatient detox programs and residential treatment centers since she had begun using heroin two decades earlier. After every release, she returned to heroin use, usually within days. Why didn’t treatment “stick”?

Inpatient 325
article thumbnail

Glasgow scientists develop first bone marrow model to support human stem cells

Pharma Times

LT-HSCs replenish blood cells after treatment for blood cancers, such as leukaemia

133
133

More Trending

article thumbnail

Study finds pain gene affects success of chronic pain medicine in women

Pharma Times

Chronic pelvic pain is a disabling condition that affects around one in four women worldwide

116
116
article thumbnail

STAT+: FDA investigators have not spoken with patients and others alleging misconduct in MDMA trials

STAT

At a contentious advisory committee meeting in June, the Food and Drug Administration announced it was investigating allegations of data suppression and misconduct in clinical trials of MDMA-assisted therapy. The agency was “quite concerned” by claims included in a report from the Institute for Clinical and Economic Review think tank, agency psychiatry director Tiffany Farchione told the ad comm, and planned to complete its investigation before deciding whether to approve Lykos The

290
290
article thumbnail

FDA launches innovation hub to spur rare disease R&D

pharmaphorum

FDA will create a rare disease hub to speed the development of new treatments and build connections between developers and the rare disease community

116
116
article thumbnail

Q&A with Dave Chokshi: Former NYC health commissioner works to unite public health and medical providers

STAT

For many New Yorkers, Dave Chokshi was the face of New York City’s public health response to Covid-19. He often appeared on public service announcements in a white lab coat emblazoned with“N-Y-C” in big, bold letters, urging urbanites to mask up , get tested , and get vaccinated. Appointed as New York City’s 43rd health commissioner in August 2020, Chokshi was thrust into the city’s battle against the coronavirus just months after it was deemed an epicenter of

Vaccines 201
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Sounds great – HCA milestone for PharmaTimes Communications Awards

Pharma Times

Accreditation recognises 'continued professional development' opportunities

article thumbnail

Novo, Lilly shares sink due to concerns over competition

STAT

Hellloooooo. Today, we discuss the FDA’s lack of engagement with critics of MDMA for PTSD therapy. We also highlight a massive veterans study on genomics, and how it illustrates the importance of studying diverse populations. And there’s more. FDA silent on claims of misconduct in MDMA trials At last month’s advisory committee meeting about Lykos Therapeutics’ MDMA-assisted therapy, the FDA said that it would investigate allegations of data suppression and misconduct

article thumbnail

Understanding PDURS: A new era for digital health and pharma

pharmaphorum

Explore the emerging era of digital health and pharmaceuticals with PDURS, featuring insights from industry experts Marty Culjat of EVERSANA and Edward Cox of Pfizer.

111
111
article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

164
164
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Chimeric antigen receptor T-cells: Emerging uses and future directions

pharmaphorum

Explore the emerging uses and future directions of chimeric antigen receptor T-cell therapy targeting mRNA, anti-EGFRvIII, and anti-NY-ESO-1 antigens in cancer treatments.

111
111
article thumbnail

Pharmacy 'vital' to pandemic response planning

The Pharmacist

The community pharmacy network must be properly funded and included in planning to improve any future response to a pandemic, the National Pharmacy Association (NPA) has said. This comes as the first report of the Covid-19 inquiry found that the UK ‘lacked resilience’ going into the pandemic, with health services under pressure and high levels […] The post Pharmacy 'vital' to pandemic response planning appeared first on The Pharmacist.

article thumbnail

NICE backs first 'take at home' prostate cancer pill

pharmaphorum

NICE backs NHS use of Accord's Orgovyx, the first therapy for advanced hormone-sensitive prostate cancer that can be taken at home

105
105
article thumbnail

IT issues: Urgent meds can be supplied under Pharmacy First

The Pharmacist

Pharmacies may need to make emergency medicine supplies under Pharmacy First amid IT issues affecting prescription systems, Community Pharmacy England (CPE) has suggested. Alastair Buxton, CPE director of NHS services, told The Pharmacist today that patients unable to contact their general practice for an urgent supply of a prescription medicine could seek assistance from NHS 111.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

GSK’s application for Blenrep for MM treatment accepted for EMA review

Pharmafile

GSK has announced that the European Medicines Agency (EMA) has accepted the marketing authorisation application (MAA) for Blenrep (belantamab mafodotin) in combination with bortezombin plus dexamethasone (BorDex) or pomalidomide plus dexamethasone (PomDex) as a treatment for relapsed or refractory (R/R) multiple myeloma (MM). The post GSK’s application for Blenrep for MM treatment accepted for EMA review appeared first on Pharmafile.

105
105
article thumbnail

Cardurion heads crop of sizeable bio financings

pharmaphorum

While the pace of biotech private rounds seems to have slowed a little of late, this week saw four big financings for Cardurion Pharma, Scorpion Therapeutics, CatalYm, and NGM Bio.Burlington, Massachusetts-based Cardurion led the quartet with a $260 million Series B for its heart-focused drug pipeline, which features two candidates in phase 2 testing – PDE9 inhibitor CRD-750 for heart failure and CaMKII inhibitor CRD-4730 for rare genetic disease catecholaminergic polymorphic ventricular tachyca

104
104
article thumbnail

Susvimo Demonstrates Sustained Efficacy Over Two Years in Patients with Diabetic Macular Edema and Diabetic Retinopathy

Pharmaceutical Commerce

FDA to review one-year results for Susvimo showing non-inferior visual acuity gains in diabetic macular edema and in the Diabetic Retinopathy Severity Scale for Diabetic Retinopathy.

Diabetes 104
article thumbnail

GSK files Blenrep in EU, seeking return to market

pharmaphorum

Less than two years after pulling multiple myeloma therapy Blenrep off most markets around the world, GSK has filed for approval of the drug in the EU once again, hoping to restore its blockbuster credentials.The remarkable renaissance for the BCMA-directed antibody-drug conjugate is supported by a pair of phase 3 trials that could not only support its return but also make it an option for a much larger patient population than before.

104
104
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Prescription chaos amid IT outages

The Pharmacist

Major IT outages have disrupted prescription access and medicines delivery today, the National Pharmacy Association (NPA) has confirmed. IT issues affecting the 'majority' of GP practices are blocking access to electronic prescriptions and patient records. And NHS England (NHSE) has suggested that paper prescriptions can be used 'to manage the disruption'.

94
article thumbnail

Avista and Hamilton Lane Join Forces to Propel Growth and Innovation at Cosette Pharmaceuticals

Outsourcing Pharma

Avista, a New York-based private equity firm focused on healthcare, and Hamilton Lane, a global private markets investment management firm, have announced that funds managed by Hamilton Lane have acquired a significant equity interest in Cosette Pharmaceuticals from Avista and its co-investors.

88
article thumbnail

Lilly alone in bidding for Morphic; Novartis won’t yet file MorphoSys drug

BioPharma Dive

Federal filings showed no companies other than Lilly made an offer to buy Morphic, while Novartis executives said they’re still waiting for more data on pelabresib.

78
article thumbnail

Phathom Pharmaceuticals receives FDA approval for Voquenza to treat non-erosive GERD

Outsourcing Pharma

Phathom Pharmaceuticals, Inc.dedicated to developing and commercializing treatments for gastrointestinal (GI) diseases, announced today that the US Food and Drug Administration (FDA) has approved Voquenza (vonoprazan) 10mg tablets for the relief of heartburn associated with non-erosive gastroesophageal reflux disease (non-erosive GERD) in adults.

82
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia

World Pharma News

Relapsed/refractory acute myeloid leukemia (AML), a so-called blood cancer, has an extremely poor prognosis because of resistance to anti-cancer drugs and frailty of the patient’s organ functions. A type of anti-tumor immunotherapy called allogeneic hematopoietic cell transplantation, which can exert anti-cancer effect accompanied by severe toxicity, is often performed for patients who are hard to treat with chemotherapy, but relapse still remains.

article thumbnail

Global tech outage hits US hospitals

BioPharma Dive

At least 11 health systems were experiencing issues Friday after an update by cybersecurity firm CrowdStrike went awry.

article thumbnail

Seventh patient ‘cured’ of HIV among highlights at AIDS 2024

Pharmaceutical Technology

New global projections and advances in HIV therapies are also on the agenda at the 25th International AIDS 2024 meeting.

64
article thumbnail

Diamyd Medical secures FDA fast track status for type 1 diabetes treatment

Pharmaceutical Business Review

This designation aims to expedite the development and review of the therapy for paediatric patients with early-stage type 1 diabetes carrying the HLA DR3-DQ2 genotype. The status aids in the development and speeding up of the review processes of medicines for treating various serious conditions and filling an unmet medical need. Diamyd, which targets the preservation of insulin production, is now recognised for its potential to address an unmet medical need in both the early and later stages of

article thumbnail

Brainomix and Boehringer Ingelheim enter strategic partnership

Pharmafile

Brainomix has announced that it has entered into a strategic partnership with Boehringer Ingelheim for a collaborative programme surrounding the care of patients with fibrosing lung disease in the US. The post Brainomix and Boehringer Ingelheim enter strategic partnership appeared first on Pharmafile.

59